Bangladesh · Delayed Price · Currency is BDT SpringWorks Therapeutics Statistics
Total Valuation
DSE:PHOENIXFIN has a market cap or net worth of BDT 597.15 million.
| Market Cap | 597.15M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Sunday, July 27, 2025.
| Earnings Date | Jul 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DSE:PHOENIXFIN has 165.87 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 165.87M |
| Shares Outstanding | 165.87M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 2.69% |
| Owned by Institutions (%) | n/a |
| Float | 143.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -0.10 |
| PB Ratio | -0.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.50
| Current Ratio | 1.50 |
| Quick Ratio | 1.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -69.93 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | -58.22M |
| Profits Per Employee | -60.91M |
| Employee Count | 103 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.10% in the last 52 weeks. The beta is 0.60, so DSE:PHOENIXFIN's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -56.10% |
| 50-Day Moving Average | 3.55 |
| 200-Day Moving Average | 3.99 |
| Relative Strength Index (RSI) | 47.93 |
| Average Volume (20 Days) | 178,282 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:PHOENIXFIN had revenue of BDT -6.00 billion and -6.27 billion in losses. Loss per share was -37.83.
| Revenue | -6.00B |
| Gross Profit | -6.00B |
| Operating Income | -6.28B |
| Pretax Income | -6.28B |
| Net Income | -6.27B |
| EBITDA | n/a |
| EBIT | n/a |
| Loss Per Share | -37.83 |
Balance Sheet
The company has 478.75 million in cash and 3.87 billion in debt, giving a net cash position of -3.39 billion or -20.45 per share.
| Cash & Cash Equivalents | 478.75M |
| Total Debt | 3.87B |
| Net Cash | -3.39B |
| Net Cash Per Share | -20.45 |
| Equity (Book Value) | -16.23B |
| Book Value Per Share | -97.85 |
| Working Capital | 8.65B |
Cash Flow
In the last 12 months, operating cash flow was -52.02 million and capital expenditures -3.34 million, giving a free cash flow of -55.36 million.
| Operating Cash Flow | -52.02M |
| Capital Expenditures | -3.34M |
| Free Cash Flow | -55.36M |
| FCF Per Share | -0.33 |
Margins
| Gross Margin | n/a |
| Operating Margin | 104.71% |
| Pretax Margin | 104.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DSE:PHOENIXFIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,050.64% |
| FCF Yield | -9.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 2, 2021. It was a forward split with a ratio of 1.12.
| Last Split Date | Aug 2, 2021 |
| Split Type | Forward |
| Split Ratio | 1.12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |